As a RBP, RBM47 inhibits lung cancer growth and metastasis by inhibiting Nuclear Factor Erythroid-2 related Factor 2 (NRF2) activity and modulating AXIN1 mRNA stability [10, 12]. The gene discussed is NFE2L2; the disease is lung cancer.